Edward A. Barker

1.7k total citations
25 papers, 1.4k citations indexed

About

Edward A. Barker is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Edward A. Barker has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Edward A. Barker's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Molecular Biology Techniques and Applications (3 papers). Edward A. Barker is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Molecular Biology Techniques and Applications (3 papers). Edward A. Barker collaborates with scholars based in United States, India and Canada. Edward A. Barker's co-authors include Edward A. Smuckler, Lance A. Liotta, Ariella M. Rosengard, Patricia S. Steeg, Allen Shearn, Joseph R. Biggs, C. Richter King, Henry C. Krutzsch, Inger Margulies and Donald C. Malins and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JNCI Journal of the National Cancer Institute.

In The Last Decade

Edward A. Barker

25 papers receiving 1.4k citations

Peers

Edward A. Barker
Karen G. Louie United States
P. Hilgard Germany
Richard D. H. Whelan United Kingdom
Lynn M. Knowles United States
Ja‐June Jang South Korea
Russell B. Myers United States
D. Lynn Kirkpatrick United States
Eric Scholar United States
Karen G. Louie United States
Edward A. Barker
Citations per year, relative to Edward A. Barker Edward A. Barker (= 1×) peers Karen G. Louie

Countries citing papers authored by Edward A. Barker

Since Specialization
Citations

This map shows the geographic impact of Edward A. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Barker more than expected).

Fields of papers citing papers by Edward A. Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward A. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Barker. The network helps show where Edward A. Barker may publish in the future.

Co-authorship network of co-authors of Edward A. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Edward A. Barker. A scholar is included among the top collaborators of Edward A. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward A. Barker. Edward A. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nassar, Aziza, Cynthia Cohen, Sally Agersborg, et al.. (2011). Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens.. Archives of Pathology & Laboratory Medicine. 135(7). 896–902. 22 indexed citations
2.
Sturmey, Roger G., Judith A. Hawkhead, Edward A. Barker, & Henry J. Leese. (2008). DNA damage and metabolic activity in the preimplantation embryo. Human Reproduction. 24(1). 81–91. 95 indexed citations
3.
Messing, Edward M., Lisa A. Teot, Howard Korman, et al.. (2005). PERFORMANCE OF URINE TEST IN PATIENTS MONITORED FOR RECURRENCE OF BLADDER CANCER: A MULTICENTER STUDY IN THE UNITED STATES. The Journal of Urology. 174(4 Part 1). 1238–1241. 51 indexed citations
4.
Malins, Donald C., et al.. (2005). A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. Proceedings of the National Academy of Sciences. 102(52). 19093–19096. 46 indexed citations
5.
Malins, Donald C., et al.. (2004). Development of a cancer DNA phenotype prior to tumor formation. Proceedings of the National Academy of Sciences. 101(29). 10721–10725. 46 indexed citations
6.
Malins, Donald C., Thomas M. Wheeler, Edward A. Barker, et al.. (2004). Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas. Proceedings of the National Academy of Sciences. 101(31). 11428–11431. 36 indexed citations
7.
Messing, Edward M., et al.. (2004). 284: Monitoring Superficial Bladder Cancer (BC) with the Immunocyt Fluorescent Cytology Test. The Journal of Urology. 171(4S). 74–75. 1 indexed citations
8.
LeMaire, William J., et al.. (2003). Neurilemmoma: an unusual benign tumor of the cervix.. PubMed. 44(3). 63–5. 4 indexed citations
9.
Malins, Donald C., Paul M. Johnson, Edward A. Barker, et al.. (2003). Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proceedings of the National Academy of Sciences. 100(9). 5401–5406. 107 indexed citations
10.
Pierce, Lori J., Maria J. Merino, Teresa D'Angelo, et al.. (1994). Is C-ERB B-2 a predictor for recurrent disease in early stage breast cancer?. International Journal of Radiation Oncology*Biology*Physics. 28(2). 395–403. 17 indexed citations
11.
Cropp, C S, Rosette Lidereau, Alvaro Leone, et al.. (1994). NME1 Protein Expression and Loss of Heterozygosity Mutations in Primary Human Breast Tumors. JNCI Journal of the National Cancer Institute. 86(15). 1167–1169. 36 indexed citations
12.
Pavelić, Zlatko P., et al.. (1992). c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.. PubMed. 52(9). 2597–602. 108 indexed citations
13.
Barnes, Robert, Edward A. Barker, Ariella M. Rosengard, et al.. (1991). Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.. PubMed. 139(2). 245–50. 146 indexed citations
14.
Rosengard, Ariella M., Henry C. Krutzsch, Allen Shearn, et al.. (1989). Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature. 342(6246). 177–180. 441 indexed citations
15.
McDaniel, M.R., Edward A. Barker, & Cindy Lederer. (1989). Sensory Characterization of Human Milk. Journal of Dairy Science. 72(5). 1149–1158. 25 indexed citations
16.
Fleckman, Philip, Gail A. Bernstein, & Edward A. Barker. (1985). Squamous cell carcinoma of the nail bed treated as chronic paronychia and wart for fourteen years.. PubMed. 36(3). 189–91. 13 indexed citations
17.
Eisele, John W., Edward A. Barker, & Edward A. Smuckler. (1976). LIPID CONTENT IN THE LIVER OF FATTY METAMORPHOSIS OF PREGNANCY. Obstetrical & Gynecological Survey. 31(7). 539–540. 16 indexed citations
18.
Barker, Edward A. & Edward A. Smuckler. (1974). Nonhepatic thioacetamide injury. II. The morphologic features of proximal renal tubular injury.. PubMed. 74(3). 575–90. 42 indexed citations
19.
Barker, Edward A. & Edward A. Smuckler. (1973). Nonhepatic thioacetamide injury. I. Thymic cortical necrosis.. PubMed. 71(3). 409–18. 14 indexed citations
20.
Barker, Edward A. & Edward A. Smuckler. (1972). Altered Microsome Function during Acute Thioacetamide Poisoning. Molecular Pharmacology. 8(3). 318–326. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026